Prolight Diagnostics publishes investor letter for August 2025

The investor letter notes, among other things, that all potential partners we met during the ADLM congress were highly impressed by Psyros’ performance, with its ability to deliver high sensitivity results combined with its sleek compact look, intelligent features and very competitively priced consumable cartridge.

The investor letter is available via the attached file or on the company’s website: https://prolightdx.com/en/mediaeng/investor-letters/